Sanofi

Showing 15 posts of 579 posts found.

Sanofi names new board member

November 20, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, bonnie bassler

Sanofi has appointed Professor Bonnie Bassler as an independent member to sit among its board of directors. Bassler has more …

Sanofi appoints an Ebola response co-ordinator

November 19, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ebola, Sanofi, gary nobel

Former director of the NIH Vaccine Research Center Dr Gary Nabel has been hired by Sanofi to spearhead its contribution …

FDA green lights Lemtrada for MS

November 17, 2014
Sales and Marketing FDA, Genzyme, Lemtrada, MS, Sanofi, rems, tecfidera

The US FDA has approved Sanofi’s Lemtrada for multiple sclerosis, almost a year after rejecting the drug on concerns about …

Perrigo acquires Omega for $4.5 billion

November 7, 2014
Manufacturing and Production, Sales and Marketing Actavis, Boehringer Ingelheim, Boehringer Ingelheim., Elan, Perrigo, Sanofi, omega

In a deal worth $4.5 billion Perrigo has announced the acquisition of over-the-counter (OTC) drugmaker Omega. This places the Irish …

Sanofi’s chief executive ousted

October 29, 2014
Medical Communications, Research and Development, Sales and Marketing Christopher Viehbacher, Sanofi

Sanofi’s chief executive Chris Viehbacher has been ejected from his role after the French firm’s board lost patience with his …

France Focus: Power without responsibility?

October 27, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing France, Lantus, Sanofi, Servier, hollande, perindopril, report

Population: 65.8 million (2013) Government: Unitary semi-presidential constitutional republic Leader: François Hollande of the centre-left Socialist Party Gross Domestic Product: …

AstraZeneca president to lead Sanofi UK

October 9, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Sanofi, Tarja Stenvall

Sanofi has appointed Tarja Stenvall to be its new general manager for the UK and Ireland. Stenvall joins Sanofi from …

Lilly and Boehringer diabetes biosimilar sees EU approval

September 11, 2014
Sales and Marketing Boehringer, EU, European Commission, Lantus, Sanofi, diabetes, lilly

Lilly and Boehringer Ingelheim’s insulin glargine product has been shown the green light by the European Commission (EC). The copycat …

Sanofi releases new diabetes app for children

September 5, 2014
Medical Communications, Sales and Marketing Gamification, Lilly board game, Sanofi, Syrum, monster manor

Sanofi Diabetes has launched a new mobile game aimed at educating children, teachers, parents and carers about living with type …

Amgen submits next gen cholesterol drug

August 29, 2014
Sales and Marketing Amgen, FDA, PCSK9, Regeneron, Sanofi, statins

Amgen has put itself in pole position in the race to market the next generation of injectable statins known as …

FDA approves Sanofi’s new rare disease drug

August 20, 2014
Research and Development, Sales and Marketing Elelyso, Gaucher disease, Genzyme, Sanofi, eliglustat

Sanofi’s biologics unit Genzyme has been granted approval for a new drug to treat the rare genetic disorder Gaucher’s disease. …

Sanofi and PATH launch large-scale malaria drug production

August 19, 2014
Manufacturing and Production, Sales and Marketing Africa, Sanofi, acts, artemisinin, malaria, path

Sanofi and global health charity PATH have come together to launch a large-scale production line of malaria jab semisynthetic artemisinin …

Sanofi signs $925 million inhaled insulin deal

August 13, 2014
Sales and Marketing Afrezza, French, Sanofi, diabetes, fad, insulin

Sanofi could pay out as much as $925 million for global rights to the world’s only approved inhaled insulin just …

Cost of diabetes treatment soars in England

August 13, 2014
Medical Communications, Research and Development, Sales and Marketing Lantus, NHS, Sanofi, diabetes

The NHS spent more than £2.2 million on average every day over the last financial year on diabetes medicines, according …

Synta appoints Sanofi president as chief executive

August 11, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Synta, anne whitaker

US biopharma firm Synta Pharmaceuticals has confirmed that Anne Whitaker is joining the company as president and chief executive. Whitaker …

The Gateway to Local Adoption Series

Latest content